KPTI
Karyopharm Therapeutics Inc
Price:  
1.09 
USD
Volume:  
951,124.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KPTI Relative Valuation

-3349.7%
Upside

As of 2024-05-24, the Relative Valuation of Karyopharm Therapeutics Inc (KPTI) is (35.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.09 USD, the upside of Karyopharm Therapeutics Inc based on Relative Valuation is -3349.7%.

The range of the Relative Valuation is (35.17) - (35.67) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 28.0x - 29.0x 28.5x
Forward P/E multiples 27.4x - 28.4x 27.9x
Fair Price (35.17) - (35.67) (35.42)
Upside -3326.7% - -3372.8% -3349.7%
1.09 USD
Stock Price
(35.42) USD
Fair Price

KPTI Relative Valuation - Historical P/E Data

Date P/E
2024-05-23 -0.87
2024-05-22 -0.88
2024-05-21 -0.89
2024-05-20 -0.91
2024-05-17 -0.92
2024-05-16 -0.90
2024-05-15 -0.90
2024-05-14 -0.87
2024-05-13 -0.89
2024-05-10 -0.87
2024-05-09 -0.85
2024-05-08 -0.81
2024-05-07 -0.88
2024-05-06 -0.92
2024-05-03 -0.90
2024-05-02 -0.86
2024-05-01 -0.86
2024-04-30 -0.82
2024-04-29 -0.88
2024-04-26 -0.84
2024-04-25 -0.84
2024-04-24 -0.87
2024-04-23 -0.87
2024-04-22 -0.90
2024-04-19 -0.93
2024-04-18 -1.02
2024-04-17 -1.10
2024-04-16 -0.88
2024-04-15 -0.92
2024-04-12 -0.97
2024-04-11 -1.07
2024-04-10 -1.01
2024-04-09 -1.07
2024-04-08 -1.07
2024-04-05 -1.08
2024-04-04 -1.06
2024-04-03 -1.02
2024-04-02 -1.11
2024-04-01 -1.26
2024-03-28 -1.20
2024-03-27 -1.18
2024-03-26 -1.11
2024-03-25 -1.11
2024-03-22 -1.11
2024-03-21 -1.13
2024-03-20 -1.11
2024-03-19 -1.09
2024-03-18 -1.17
2024-03-15 -1.20
2024-03-14 -1.07